New Releases from NCBI BookshelfComparing Stopping or Continuing Use of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis—The DISCOMS Trial [Internet].Comparing Stopping or Continuing Use of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis—The DISCOMS Trial [Internet].
The onset of multiple sclerosis (MS) is most common between ages 25 and 40 years, with the risk of new […]
